A patient on hydroxyurea for sickle cell disease who developed an opportunistic infection

Autor:	Pramila Venigalla, Anitha Nallari, Sandra Allen, Maxwell P. Westerman, Manoj Agarwal, Bharat Motwani, Manuel Alva, Lawrence Feldman
Rok vydání:	2002
Předmět:	Drug business.industry Opportunistic infection media_common.quotation_subject Immunology Cell Cell Biology Hematology Disease medicine.disease Biochemistry medicine.anatomical_structure hemic and lymphatic diseases Medicine business media_common
Zdroj:	Blood. 100:363-364
ISSN:	1528-0020 0006-4971
DOI:	10.1182/blood-2002-03-0754
Popis:	Recent reports[1-7][1] indicate that hydroxyurea (HU) is safe and effective in the treatment of patients with severe sickle cell disease (SCD). In particular, there have been no reports of any patient developing an opportunistic infection while taking this drug. Below, we report a case of
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::9262cce8bd2c787970e671cca75dcc42 https://doi.org/10.1182/blood-2002-03-0754 Zobrazit plný text záznamu